Labcorp (NYSE: LH) grants stock options and RSUs to SVP

Rhea-AI Filing Summary

Labcorp Holdings Inc. reported that SVP and Chief Accounting Officer Peter J. Wilkinson acquired new equity awards on February 10, 2026. He received non-qualified stock options for 1,300 shares of common stock with an exercise price of $284.5 per share, granted under the 2025 Omnibus Incentive Plan. These options vest in three equal annual installments starting on that grant date and expire on February 9, 2036.

Wilkinson was also granted 440 Restricted Stock Units, each representing one share of common stock, vesting in three equal annual installments beginning on February 10, 2027. Following this grant, he holds 2,664 Restricted Stock Units in total, all reported as directly owned.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Wilkinson Peter J

Role SVP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Non-qualified Stock Options	1,300	$0.00	--
Grant/Award	Restricted Stock Unit	440	$0.00	--

Holdings After Transaction: Non-qualified Stock Options — 1,300 shares (Direct); Restricted Stock Unit — 2,664 shares (Direct)

Footnotes (1)

1. Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. The option vests in three equal annual installments beginning on the date reflected in this column. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkinson Peter J

(Last) (First) (Middle)

231 MAPLE AVENUE

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Options(1)	$284.5	02/10/2026		A		1,300		02/10/2027(2)	02/09/2036	Common Stock	1,300	$0	1,300	D
Restricted Stock Unit	(3)	02/10/2026		A		440		(4)	(4)	Common Stock	440	$0	2,664(5)	D

Explanation of Responses:

1. Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.

2. The option vests in three equal annual installments beginning on the date reflected in this column.

3. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

4. The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.

5. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Peter J. Wilkinson	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Labcorp (LH) grant to Peter J. Wilkinson?

Labcorp granted Peter J. Wilkinson 1,300 non-qualified stock options and 440 Restricted Stock Units. The options have a $284.5 exercise price, while each RSU represents one share of common stock, both granted as part of his executive compensation package.

When do Peter J. Wilkinson’s new Labcorp stock options vest?

The 1,300 non-qualified stock options vest in three equal annual installments. Vesting begins on February 10, 2026, the grant date, and continues annually until fully vested, with the options scheduled to expire on February 9, 2036 if not exercised.

How do the new Labcorp Restricted Stock Units for Peter J. Wilkinson vest?

The 440 Restricted Stock Units vest in three equal annual installments. The vesting schedule starts on February 10, 2027, and each RSU represents the right to receive one share of Labcorp common stock upon vesting, subject to continued eligibility.

How many Labcorp Restricted Stock Units does Peter J. Wilkinson now hold?

After the February 10, 2026 grant, Peter J. Wilkinson holds 2,664 Restricted Stock Units. This figure reflects the aggregate number of RSUs beneficially owned by him, all reported as directly held in the Form 4 filing.

What is the exercise price and term of Peter J. Wilkinson’s new Labcorp options?

The newly granted 1,300 non-qualified stock options have a $284.5 exercise price. They were granted on February 10, 2026 and are scheduled to expire on February 9, 2036, providing a 10-year term from the grant date.